IL-6

You have access
Isophysalin A Inhibits the Stemness of Breast Cancer Cells Possibly via Stat3 and IL-6 Signaling
YU-CHAN KO, HACK SUN CHOI, SU-LIM KIM and DONG-SUN LEE

Anticancer Research March 2023, 43 (3) 1091-1101; DOI: https://doi.org/10.21873/anticanres.16254
You have access
Kruppel-like Factor 2 Inhibits Proliferation in Renal Angiomyolipoma via IL-6/JAK/STAT3 Signaling Pathway
CHUNG-YI LIU, TZU-HSUAN CHANG, CHIN-HSUAN HSIEH, YING-HSU CHANG, JACOB SEE-TONG PANG and CHENG-KENG CHUANG

Anticancer Research October 2022, 42 (10) 4753-4762; DOI: https://doi.org/10.21873/anticanres.15980
You have access
The Interaction Between Cancer-associated Fibroblasts and Cancer Cells Enhances Bcl-xL and Mcl-1 in Colorectal Cancer
ANRI MAEDA, HIROKI TAKAHASHI, SHINNOSUKE HARATA, KAORI WATANABE, TAKESHI YANAGITA, TAKUYA SUZUKI, HAJIME USHIGOME, NOZOMU NAKAI, YUZO MAEDA, TAKAHISA HIROKAWA, KAZUYOSHI SHIGA, RYO OGAWA, MASAYASU HARA, YOICHI MATSUO, AKIRA MITSUI, MASAHIRO KIMURA and SHUJI TAKIGUCHI

Anticancer Research March 2022, 42 (3) 1277-1288; DOI: https://doi.org/10.21873/anticanres.15594
You have access
Soluble Factors Involved in Cancer Cell–Macrophage Interaction Promote Breast Cancer Growth
KIMIHIRO YONEMITSU, YUKO MIYASATO, TAKUYA SHIOTA, YUSUKE SHINCHI, YUKIO FUJIWARA, SEIJI HOSAKA, YUTAKA YAMAMOTO and YOSHIHIRO KOMOHARA

Anticancer Research September 2021, 41 (9) 4249-4258; DOI: https://doi.org/10.21873/anticanres.15229
You have access
Are Proinflammatory Cytokines Relevant for the Diagnosis of Prostate Cancer?
MANUEL M. GARRIDO, RUY M. RIBEIRO, KIMBERLY KRÜGER, LUÍS C. PINHEIRO, JOÃO T. GUIMARÃES and STEFAN HOLDENRIEDER

Anticancer Research June 2021, 41 (6) 3067-3073; DOI: https://doi.org/10.21873/anticanres.15090
Open Access
The Mechanism of the Synergistic Anticancer Effect of CDDP and EPA in the TE1 Cell Line
AYAKO OGO, SACHI MIYAKE, HISAKO KUBOTA, MASAHARU HIGASHIDA, HIDEO MATSUMOTO, FUSAKO TERAMOTO, TOSHIHIRO HIRAI and TOMIO UENO

Anticancer Research April 2021, 41 (4) 1771-1778; DOI: https://doi.org/10.21873/anticanres.14942
You have access
Lymphocytes, Interleukin 6 and D-dimer Cannot Predict Clinical Outcome in Coronavirus Cancer Patients: LyNC1.20 Study
GIANLUCA VANNI, MARCO MATERAZZO, MARIO DAURI, ANDREA FARINACCIO, CHIARA BUONOMO, ILARIA PORTARENA, MARCO PELLICCIARO, JACOPO MARIA LEGRAMANTE, STEFANO RIZZA, CARLO CHIARAMONTE, ALFONSO BELLIA, MICHELE GRANDE, SAVERIO POTENZA, FRANCESCO PAOLO SBORDONE, MARCO ALFONSO PERRONE, FRANCESCO GRIMALDI, MARCELLO CHIOCCHI and ORESTE CLAUDIO BUONOMO

Anticancer Research January 2021, 41 (1) 307-316; DOI: https://doi.org/10.21873/anticanres.14777
You have access
2-Phenylnaphthyridin-4-one Derivative LYF-11 Inhibits Interleukin-6-mediated Epithelial–to–Mesenchymal Transition via the Inhibition of JAK2/STAT3 Signaling Pathway in MCF-7 Cells
LIANG-CHIH LIU, YAO-CHUNG WU, SHENG-CHU KUO, CHI-TANG HO, TZONG-DER WAY and SHOU-TUNG CHEN

Anticancer Research May 2018, 38 (5) 2849-2859;
You have access
Does the Rectus Sheath Block Analgesia Reduce the Inflammatory Response Biomarkers' IL-1ra, IL-6, IL-8, IL-10 and IL-1β Concentrations Following Surgery? A Randomized Clinical Trial of Patients with Cancer and Benign Disease
MARTIN PURDY, MERJA KOKKI, MAARIT ANTTILA, SAMULI ASPINEN, PETRI JUVONEN, RIIKA KORHONEN, TUOMAS SELANDER, HANNU KOKKI and MATTI ESKELINEN

Anticancer Research June 2016, 36 (6) 3005-3011;
You have access
Determination of Interleukin-4, -5, -6, -8 and -13 in Serum of Patients with Breast Cancer Before Treatment and its Correlation to Circulating Tumor Cells
ALEXANDER KÖNIG, THERESA VILSMAIER, BRIGITTE RACK, KLAUS FRIESE, WOLFGANG JANNI, UDO JESCHKE, ULRICH ANDERGASSEN, ELISABETH TRAPP, JULIA JÜCKSTOCK, BERNADETTE JÄGER, MARIANNA ALUNNI-FABBRONI, THOMAS FRIEDL, TOBIAS WEISSENBACHER and SUCCESS STUDY GROUP

Anticancer Research June 2016, 36 (6) 3123-3130;

Main menu

User menu

Search

IL-6

Pages